Concluding in- and out- licensing agreements for your unique formulations and brands to be marketed in Indian and overseas market
Concluding Distribution and Marketing or co-marketing agreements for overseas markets. At Oxy Group we help builds “molecules into brands.” We work with our distributors, strategically and programmatically, to accelerate, expand and extend the product life cycles of ethical drugs. OXY GROUP has developed considerable brand marketing experience in the emerging markets through its portfolio of branded generics. We focus on new generations of drugs thereby ascending the value chain in the marketing and ultimately increase revenues from the sales of our products.
With state-of-the-art infrastructure, advanced research capability, regulatory experience and availability of trained manpower makes Oxy Group a preferred contract research destination.
We offer flawless execution of formulation development projects with a team of experienced scientists and quality personals with world class infrastructure.
For Oxy Group’s USFDA Compliance and accredited plant from various regulatory authorities across the globe, we actively look for partners to render contract manufacturing services through technology transfer as well. Our products are available under private label to our distributors and partners in most countries. In order to satisfy the diverse needs of our various customers located in different parts of the world we believe in developing products specific to the requirements of our customers.
The people of Oxy Group have headed various joint venture projects to manufacture a diverse range of products from Veterinary pharmaceutical formulations to veterinary pre-mixes in countries like Nepal, Bangladesh, Srilanka, Bhutan and Turkey. We are able to do so by offering turnkey projects to our overseas associates for establishing a state of the art manufactoring from conception to commencement stage.
Our Regulatory team consists of elite, highly qualified personnel engaged in providing data required to assure the high Quality, efficacy and safety of our Products. We can provide, clinical Trials, FDA Certificates and BE Studies for registration of our products as per guidelines of most health authorities in most countries.
We understand that distribution of veterinary pharmaceutical products must be undertaken with a great deal of care and attention. Raw materials awaiting processing and finished products awaiting dispatch are stored in modern, fully climate-controlled high-bay storage areas. OXY GROUP is able to meet the delivery needs of its customers thanks to its modern data and order processing systems, its inspections of all goods entering and leaving the factory, and the latest transport logistics (road, sea or air). No matter what route The OXY GROUP product takes, or how long it takes to get there, its journey is carefully monitored until it reaches its destination. In a nutshell, the factors that have made us successful in drug manufacturing for overseas markets are coverage.
R & D
We are coming up with an R & D centre in Mumbai. The activity profile will include:
- Formulation Development
- Bio-equivalence studies
- Efficacy in vivo and in vitro
- Determination of withdrawal period in meat, milk and eggs
- Safety and toxicity in target species